Lifecore Biomedical Inc.
LFCR
$6.45+0.31%
End of day · as of Oct 11, 2026, 8:01 AM ET
Mkt cap
$207.05M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2026-06-30)
$34.17M
EPS (H1 2026)
$-0.61
Gross Margin (qtr ended 2026-06-30)
35.34%
Profit Margin (qtr ended 2026-06-30)
-18.02%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported LFCR revenue for 2026-06-30 was $34.2M. Net income was -$6.2M. Revenue was up 47.3% from 2026-03-31 to 2026-06-30. LFCR currently screens at market cap $207.1M.
Use this LFCR research hub for sector, financials, and filings — not a live tape.
Each line names its own latest cached period. Full LFCR income, balance, and cash tables.
† Total Debt (Q2 2026): Derived: short-term debt plus long-term debt (no total debt stored).
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Lifecore Biomedical Inc. (LFCR) revenue for Jun 30, 2026 was $34.2M. Net income was -$6.2M. Statements: https://lician.com/financials/lfcr
Lifecore Biomedical Inc. (LFCR) market capitalization is $207.1M on the latest cached snapshot.
Lifecore Biomedical Inc. (LFCR) cached previous close $6.43; day range $6.42 – $6.46; volume 387,063. Session quote: https://lician.com/quote/lfcr
Lifecore Biomedical Inc. (LFCR) latest cached earnings event is "LFCR earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached LFCR filing is 8-K · Sep 29, 2026. Filings: https://lician.com/sec/lfcr